Halozyme Therapeutics | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amarin USD 0 8K 2024-06
Amgen USD 747M 29M 2024-12
Baxter International USD 100M 1000K 2024-12
Cytokinetics USD 22.59M 296K 2024-12
DBV Technologies 784.71K 632.24K 2022-06
Eli Lilly USD 224.7M 78.4M 2024-12
Halozyme Therapeutics USD 4.54M 16K 2024-12
Indivior 9M 1000K 2024-09
Intra Cellular Therapies 5.97M 966K 2023-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
MannKind USD 7.48M 879K 2024-12
Pfizer USD 739M 45M 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12



Halozyme Therapeutics Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.